Ni et al., through a single-cell exome sequencing, identified EGFR, PIK3CA, RB1, and TP53 mutations in CTCs of a patient with transformed SCLC, with higher abundance than in the original NSCLC [75]. This evidence concerns the gene TP53 and small cell lung carcinoma.